# Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo

> **NCT05238077** · NA · TERMINATED · sponsor: **Henry Ford Health System** · enrollment: 1 (actual)

## Conditions studied

- Generalized Vitiligo

## Interventions

- **PROCEDURE:** Visible Light-Ultraviolet A Light or Narrowband-Ultraviolet B phototherapy

## Key facts

- **NCT ID:** NCT05238077
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-26
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-06-02
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** only one subject enrolled, decided to re-evaluate protocol design
- **Last updated:** 2022-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05238077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05238077, "Comparing the Efficacy of Visible Light-Ultraviolet A1 Light Versus Narrowband-Ultraviolet B on Generalized Vitiligo". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05238077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*